Regeneron says jury verdict against Amgen shows anticompetitive efforts won't remain unchecked
MLex Summary: Regeneron Pharmaceuticals today applauded a jury verdict awarding it $135.6 million in compensatory damages and $271.2 million in punitive damages against Amgen in an antitrust suit. "Today’s verdict validates...To view the full article, register now.
Already a subscriber? Click here to view full article